A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects



Status:Archived
Conditions:Parkinsons Disease
Therapuetic Areas:Neurology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:July 2010

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Phase 2 Efficacy, Safety and Pharmacokinetic Study of XP21279 BL2 and Sinemet® in Parkinson's Disease Subjects With Motor Fluctuations


The purpose of the study is to assess the efficacy and safety of XP21279/Carbidopa in
comparison to Sinemet as well as evaluate the pharmacokinetics (PK) of levodopa after
administration of XP21279/Carbidopa and Sinemet and to explore exposure-response
relationships in a subset of subjects.



We found this trial at
9
sites
XenoPort Clinical Site
Bingham Farms, Michigan 48025
?
mi
from
Bingham Farms, MI
Click here to add this to my saved trials
XenoPort Clinical Site
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials
XenoPort Clinical Site
Kansas City, Kansas 66160
?
mi
from
Kansas City, KS
Click here to add this to my saved trials
XenoPort Clinical Site
Little Rock, Arkansas 72205
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
XenoPort Clinical Site
Long Beach, California 90806
?
mi
from
Long Beach, CA
Click here to add this to my saved trials
XenoPort Clinical Site
Naples, Florida 34102
?
mi
from
Naples, FL
Click here to add this to my saved trials
UMDNJ-Robert Wood Johnson Medical Center
New Brunswick, New Jersey 08901
?
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
XenoPort Clinical Site
New Brunswick, New Jersey 08901
?
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
XenoPort Clinical Site
Tulsa, Oklahoma 74137
?
mi
from
Tulsa, OK
Click here to add this to my saved trials